Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles L Sentman

Showing results (71-80 of 77) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 77 results.
Cancer Immunology Research|June 13, 2022
Superkine IL-2 and IL-33 Armored CAR T Cells Reshape the Tumor Microenvironment and Reduce Growth of Multiple Solid TumorsRachel A Brog, Shannon L Ferry, Courtney T Schiebout, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 29, 2022
Multifunctional mRNA-Based CAR T Cells Display Promising Antitumor Activity Against GlioblastomaHanna Meister, Thomas Look, Patrick Roth, et al.
Cancer Research|September 5, 2008
Depletion of dendritic cells delays ovarian cancer progression by boosting antitumor immunityEduardo Huarte, Juan R Cubillos-Ruiz, Yolanda C Nesbeth, et al.
The Journal of Clinical Investigation|July 22, 2009
Polyethylenimine-based siRNA nanocomplexes reprogram tumor-associated dendritic cells via TLR5 to elicit therapeutic antitumor immunityJuan R Cubillos-Ruiz, Xavier Engle, Uciane K Scarlett, et al.
Elife|November 14, 2015
A forward genetic screen reveals novel independent regulators of ULBP1, an activating ligand for natural killer cellsBenjamin G Gowen, Bryan Chim, Caleb D Marceau, et al.
Cytotherapy|September 6, 2018
Manufacturing development and clinical production of NKG2D chimeric antigen receptor-expressing T cells for autologous adoptive cell therapyJoana M Murad, Susanne H Baumeister, Lillian Werner, et al.
Cancer Immunology Research|November 7, 2018
Phase I Trial of Autologous CAR T Cells Targeting NKG2D Ligands in Patients with AML/MDS and Multiple MyelomaSusanne H Baumeister, Joana Murad, Lillian Werner, et al.
Pageof 8

Showing results (71-80 of 77) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
Cancer Immunology Research|June 13, 2022
Superkine IL-2 and IL-33 Armored CAR T Cells Reshape the Tumor Microenvironment and Reduce Growth of Multiple Solid TumorsRachel A Brog, Shannon L Ferry, Courtney T Schiebout, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 29, 2022
Multifunctional mRNA-Based CAR T Cells Display Promising Antitumor Activity Against GlioblastomaHanna Meister, Thomas Look, Patrick Roth, et al.
Cancer Research|September 5, 2008
Depletion of dendritic cells delays ovarian cancer progression by boosting antitumor immunityEduardo Huarte, Juan R Cubillos-Ruiz, Yolanda C Nesbeth, et al.
The Journal of Clinical Investigation|July 22, 2009
Polyethylenimine-based siRNA nanocomplexes reprogram tumor-associated dendritic cells via TLR5 to elicit therapeutic antitumor immunityJuan R Cubillos-Ruiz, Xavier Engle, Uciane K Scarlett, et al.
Elife|November 14, 2015
A forward genetic screen reveals novel independent regulators of ULBP1, an activating ligand for natural killer cellsBenjamin G Gowen, Bryan Chim, Caleb D Marceau, et al.
Cytotherapy|September 6, 2018
Manufacturing development and clinical production of NKG2D chimeric antigen receptor-expressing T cells for autologous adoptive cell therapyJoana M Murad, Susanne H Baumeister, Lillian Werner, et al.
Cancer Immunology Research|November 7, 2018
Phase I Trial of Autologous CAR T Cells Targeting NKG2D Ligands in Patients with AML/MDS and Multiple MyelomaSusanne H Baumeister, Joana Murad, Lillian Werner, et al.
Pageof 8